PILL - Direxion Daily Pharmaceutical & Medical Bull 3X Shares
|Ex-Dividend Date||Sep 24, 2019|
|Trading Day||April 20|
|Day's Range||18.94 - 19.78|
|52-Week Range||11.60 - 31.86|
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
|Asset Class |
|Inception Date |
Nov 15, 2017
|Ticker Symbol |
|Index Tracked |
Dynamic Pharmaceutical Intellidex Index
Top 10 Holdings81.85% of assets
|S&P Pharmaceuticals Select Index SWAP||n/a||52.35%|
|S&P PHARMACEUTICALS SELECT INDEX SWAP||n/a||13.88%|
|BANK OF NEW YORK CASH RESERVE||n/a||4.69%|
|GOLDMAN FINL SQ TRSRY INST 506||n/a||3.03%|
|S&P Pharmaceuticals Select Index SWAP||n/a||1.83%|
|DREYFUS GOVT CASH MGMT||n/a||1.78%|
|GOLDMAN FINL SQ TRSRY INS||n/a||1.24%|
|Dec 23, 2019||$0.00||Dec 31, 2019|
|Sep 24, 2019||$0.015||Oct 1, 2019|
|Jun 25, 2019||$0.022||Jul 2, 2019|
|Mar 19, 2019||$0.057||Mar 26, 2019|
|Dec 27, 2018||$0.099||Jan 4, 2019|
|Sep 25, 2018||$0.043||Oct 2, 2018|
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is up about 20% the past month, which is making it an easy pill to swallow for traders looking to capitalize on this sub-sector of h...
Last week witnessed a tug-of-war between bulls and bears.
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performances ...